TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | 4 | 2 | -9 | -44 | 0 | -9 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/19 16:33 | 8/13/19 | ASRT | Assertio Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Bukofzer Stan | IL | O | SVP,Chf | P | 6 | 1.56 | 0 | 4 | 17 | 27 | D | ||||||||||||||
3/18/19 08:01 | 3/14/19 | ASRT | Assertio Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Bukofzer Stan | IL | O | SVP,Chf | P | 21 | 4.13 | 0 | 5 | New | 5 | D | ||||||||||||||
10/17/16 08:28 | 10/13/16 | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bukofzer Stan | CA | O | Chief Me | P | 7 | 2.64 | 1 | 3 | New | 3 | D | -53 | -37 | -19 | -14 | 6 | -7 | -17 | -15 | 2 | 4 | 2 | -9 | -44 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |